Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-03

Clinical Trial Update: MRI Guided Radiation Therapy for the Treatment of High Risk Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating MRI-guided radiation therapy for high-risk prostate cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Thomas Jefferson University | Conditions: Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8 | Phase 2 | Status: TERMINATED